RAPP - CIK 0002012593
Rapport Therapeutics, Inc. (RAPP) reported net income of -$111.48M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$111.48M | -42.4% |
| FY 2024 | -$78.31M | -125.1% |
| FY 2023 | -$34.79M | - |
Rapport Therapeutics, Inc. (RAPP) reported net income of -$111.48M for fiscal year 2025, as filed in its audited annual report with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.